McCutcheon, Sean R.
Swartz, Adam M.
Brown, Michael C.
Barrera, Alejandro http://orcid.org/0000-0001-9244-9822
McRoberts Amador, Christian
Siklenka, Keith
Humayun, Lucas http://orcid.org/0000-0003-4624-2550
ter Weele, Maria A.
Isaacs, James M.
Reddy, Timothy E. http://orcid.org/0000-0002-7629-061X
Allen, Andrew S.
Nair, Smita K. http://orcid.org/0000-0001-7019-1912
Antonia, Scott J.
Gersbach, Charles A. http://orcid.org/0000-0003-1478-4013
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (UM1HG013053, UM1HG009428, RM1HG011123)
National Science Foundation (EFMA-1830957)
Article History
Received: 18 July 2023
Accepted: 26 September 2023
First Online: 9 November 2023
Competing interests
: S.R.M. and C.A.G. are named inventors on patent applications related to epigenome engineering technologies in primary human T cells. S.R.M. is a consultant for Tune Therapeutics. C.A.G. is a co-founder of Tune Therapeutics and Locus Biosciences, and is an advisor to Sarepta Therapeutics. The remaining authors declare no competing interests.